PHARMACOKINETICS AND SAFETY OF A NOVEL APOLIPOPROTEIN A-I THERAPY, CSL112, IN ADULTS WITH MODERATE RENAL IMPAIRMENT (RI) AND NORMAL RENAL FUNCTION

M. A. Tortorici, D. Duffy,M. Zhou, R. Evans, J. Feaster, D. D'Andrea

CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要